These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31960533)

  • 41. Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings.
    Fu R; Altamirano J; Sarnquist CC; Maldonado YA; Andrews JR
    Clin Infect Dis; 2018 Oct; 67(suppl_1):S26-S34. PubMed ID: 30376087
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
    Fine PE; Carneiro IA
    Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of disruptions caused by the COVID-19 pandemic on global polio eradication.
    Kalkowska DA; Voorman A; Pallansch MA; Wassilak SGF; Cochi SL; Badizadegan K; Thompson KM
    Vaccine; 2023 Apr; 41 Suppl 1():A12-A18. PubMed ID: 33962838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs.
    Duintjer Tebbens RJ; Thompson KM
    BMC Infect Dis; 2015 Sep; 15():390. PubMed ID: 26404780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [POLIOMYELITIS ERADICATION--ONE STEP TO ACHIEVE THE GOAL].
    Ljubin-Sternak S; Kaić B; Vilibić-Čavlek T; Mlinarić-Galinović G
    Acta Med Croatica; 2014 Dec; 68(4-5):327-35. PubMed ID: 26285465
    [TBL] [Abstract][Full Text] [Related]  

  • 46. National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.
    Thompson KM; Duintjer Tebbens RJ
    Expert Rev Vaccines; 2014 Feb; 13(2):221-34. PubMed ID: 24308581
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polio Endgame, Information Gaps Related to Vaccines and Immunity.
    Ahmad M; Bahl S; Kunwar A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S33-S37. PubMed ID: 27771637
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication.
    Modlin JF; Bandyopadhyay AS; Sutter R
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S398-S404. PubMed ID: 34590135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication.
    Kew O; Pallansch M
    Annu Rev Virol; 2018 Sep; 5(1):427-451. PubMed ID: 30001183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Progress Toward Poliomyelitis Eradication - Worldwide, January 2021-March 2023.
    Lee SE; Greene SA; Burns CC; Tallis G; Wassilak SGF; Bolu O
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(19):517-522. PubMed ID: 37167156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The polio endgame.
    Minor P
    Hum Vaccin Immunother; 2014; 10(7):2106-8. PubMed ID: 25608050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
    Duintjer Tebbens RJ; Thompson KM
    Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
    Duintjer Tebbens RJ; Thompson KM
    J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Borno and Yobe in Northeast Nigeria.
    Kalkowska DA; Thompson KM
    Risk Anal; 2021 Feb; 41(2):303-311. PubMed ID: 32348634
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Polio vaccines, eradication and posterradication].
    Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
    Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
    Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The lost decade of global polio eradication and moving forward].
    Shimizu H
    Uirusu; 2010 Jun; 60(1):49-58. PubMed ID: 20848864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The new polio eradication end game: rationale and supporting evidence.
    Sutter RW; Platt L; Mach O; Jafari H; Aylward RB
    J Infect Dis; 2014 Nov; 210 Suppl 1():S434-8. PubMed ID: 25316865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new challenge for the world: the eradication of polio.
    Gentile Á; Abate H
    Arch Argent Pediatr; 2016 Dec; 114(6):557-562. PubMed ID: 27869415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.